Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Davanat progress updated

Nov. 11, 2004

Pharmacia claims combined therapy against tumors

Nov. 10, 2004

Ginseng derivative shows SERM activity

Nov. 10, 2004

Advexin plus chemotherapy effective against head and neck cancer cells

Nov. 10, 2004

Aventis terminates Genasense agreements with Genta

Nov. 10, 2004

IDM, Walter Reed Army Institute of Research sign cancer vaccine agreement

Nov. 10, 2004

Peplin to raise funds to support phase II studies of PEP-005 Topical

Nov. 10, 2004

Indian researchers isolate new cytotoxic terpenes from plants

Nov. 9, 2004

Affimed Therapeutics and Syngenta to codevelop Tandab antibody

Nov. 9, 2004

Marqibo submitted for marketing approval in Canada

Nov. 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...